... of effective therapies: Johns Hopkins University pathologist Akhilesh Pandey has identified an epidermal growth factor receptor aberrantly active in approximately a third of the 250 human pancreatic ...
... because of over-expression of a protein known as the epidermal growth factor receptor (EGFR) or a peptide hormone ... Argos-like drug would instead neutralize the cancer growth factor by mimicking a silent ...
Scientists have uncovered a previously unrealized mechanism by which the epidermal growth factor receptor (EGFR), a tyrosine kinase, promotes survival of cancer cells through a kinase-independent ...
... the entire class of drugs known as epidermal growth factor receptor (EGFR) tyrosine kinase ... 60 percent of women with breast cancer are hormone receptor positive and Her-2 negative, said Cristofanilli. ...
... no treatment options for NSCLC patients in whom chemotherapy failed. Iressa, which disables the epidermal growth factor receptor (EGFR) on the surface of lung cancer cells, was approved in 2003 for ...
... -molecule inhibitor of both HER2 and the epidermal growth factor receptor (EGFR), is able to cross ... 1731
Modified Salmonella Slows Tumor Growth
Attenuated Salmonella bacteria engineered to express ...
... IKKα spontaneously induced squamous cell carcinomas by activating the epidermal growth factor receptor pathway," said senior author Yinling Hu, Ph.D., assistant professor in M. D ...
... the new therapies, such as erlotinib and cetuximab, work against the signals that come from epidermal growth factor receptor (EGFR), which drives out-of-control growth in head and neck cancer cells. ...
... non-small-cell lung cancer and screened them for two common mutations in the gene for epidermal growth factor receptor, which can be a cause of lung cancer.
The two mutations ...
... factors bind to cell surface receptors, including epidermal growth factor receptor (EGFR), K- ... temporarily activated, facilitating regulated cell growth and proliferation.
The K-Ras gene is mutated ...
... .
"Around 50% to 60% of this population have tumors with mutations in the epidermal growth factor receptor, and we know that patients with such mutations have a significantly better treatment ...
... heat, but whose effects in the body are well known. The antibody they used targets epidermal growth factor receptor (EGFR), a cell-surface receptor implicated in cancer.
These "tagged" antibodies ...
... cancers and continues to be a major unsolved health problem. The overexpression of the epidermal growth factor receptor and its ligands correlates with rapidly progressive disease and resistance to ...
... In avb3-blocked cells, a5b1 became associated with epidermal growth factor receptor 1 (EGFR1), which increased EGFR1's abundance at the membrane protrusions, as well as its ...
... III trial. The compound, XL184, targets cell growth and migration, as well as blood vessel ... class of targeted drugs that zero in on the epidermal growth factor receptor (EGFR) gene, which is mutated ...
